FDA Moves Ahead With MMJ Cannabis Drug Application
Cannabis News
February 23, 2024
MMJ International Holdings Develops Botanical Extract for FDA Clinical Trials in Multiple Sclerosis and Huntington’s Disease. MMJ International Holdings has manufactured a botanical extract in a final dose form gel cap and will investigate its novel cannabis medicine in FDA clinical trials to prove
Credit:Source link